SAB Biotherapeutics, Inc. (SABS)

SAB Biotherapeutics Revenue

SAB Biotherapeutics had revenue of $1.51M in the twelve months ending September 30, 2024, down -63.06% year-over-year. In the year 2023, SAB Biotherapeutics had annual revenue of $2.24M, down -90.63%.

• Revenue (ttm): $1.51M
• Revenue Growth: -63.06%
• P/S Ratio: 20.88
• Revenue / Employee: $26,539
• Employees: 57
• Market Cap: 32.76M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.24M	-21.67M	-90.63%
Dec 31, 2022	23.90M	-36.97M	-60.73%
Dec 31, 2021	60.88M	5.64M	10.21%
Dec 31, 2020	55.24M	51.80M	1,504.91%
Dec 31, 2019	3.44M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.